About Qlaris Bio
Qlaris Bio is a private company based in Dedham, Massachusetts. It has reported $41,785,467 raised in four offerings on Form D since August 2019. Its chief executive is Frederic Guerard.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jun 12, 2026 | Jun 17, 2026 | $3,946,659fully sold | 8 | $493K | Debt, Options, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Nov 13, 2025 | Nov 17, 2025 | $5,641,600fully sold | 8 | $705K | Debt, Options, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Apr 11, 2024 | Apr 22, 2024 | $24,032,554fully sold | 8 | $3.0M | EquityRule 506(b) | Form D ↗ |
| Aug 13, 2019 | Aug 28, 2019 | $8,164,654of $27.3M target | 6 | $1.3M | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $41,785,467 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Qlaris Bio's Form D filed Jun 17, 2026.
BW
AG
WH
Wende Hutton
Director
RW
Robert Warner
Director
FG
Frederic Guerard
President and Chief Executive Officer, director
Also a director at Lenz Therapeutics and Spiral Therapeutics.
RH
Ronald Hunt
Director
AD
Andrew Danielson
Director
Earlier filings also listed Thurein Htoo (chief executive officer and director, last listed Nov 2025) and Andrew Danielsen (director, last listed Aug 2019).